DRW Securities’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,522
Closed -$1.11M 1068
2026
Q1
$1.11M Buy
15,522
+10,230
+193% +$788K 0.02% 303
2025
Q4
$418K Buy
+5,292
New +$417K 0.01% 523
2025
Q3
Sell
-38,090
Closed -$2.63M 1347
2025
Q2
$2.63M Buy
+38,090
New +$2.5M 0.06% 173
2025
Q1
Sell
-46,252
Closed -$2.08M 631
2024
Q4
$2.08M Buy
+46,252
New +$2.59M 0.07% 146
2024
Q2
Sell
-6,379
Closed -$509K 546
2024
Q1
$509K Buy
+6,379
New +$487K 0.01% 227
2023
Q2
Sell
-8,287
Closed -$616K 361
2023
Q1
$616K Buy
+8,287
New +$695K 0.01% 180
2022
Q4
Sell
-3,548
Closed -$338K 277
2022
Q3
$338K Buy
+3,548
New +$351K 0.01% 173
2022
Q2
Sell
-6,308
Closed -$638K 268
2022
Q1
$638K Buy
6,308
+2,819
+81% +$296K 0.02% 157
2021
Q4
$360K Buy
+3,489
New +$322K 0.01% 169
2021
Q3
Sell
-4,162
Closed -$347K 277
2021
Q2
$347K Buy
+4,162
New +$341K 0.01% 211
2020
Q1
Sell
-15,345
Closed -$1.14M 298
2019
Q4
$1.14M Buy
+15,345
New +$1.08M 0.04% 85
2018
Q1
Sell
-14,208
Closed -$1.03M 244
2017
Q4
$1.03M Buy
+14,208
New +$1.03M 0.11% 120
2014
Q1
Sell
-2,804
Closed -$201K 146
2013
Q4
$201K Buy
+2,804
New +$180K 0.01% 185

Other funds holding CVS

DRW Securities's CVS Position: Q2 2026 in Review

DRW Securities sold out of CVS Health (CVS) in Q2 2026, closing a stake of 15,522 shares — an estimated $1.11M sold.

DRW Securities first reported a position in CVS in Q4 2013 and held it in 13 quarters. The position peaked at $2.63M in Q2 2025. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • DRW Securities reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • DRW Securities sold 15,522 CVS Health shares in Q2 2026, an estimated $1.11M.
  • DRW Securities first reported a position in CVS Health in Q4 2013 and held it in 13 quarters.
  • DRW Securities's CVS Health position peaked at $2.63M in Q2 2025.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.